+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Connected Drug Delivery Devices Market Size, Share & Trends Analysis Report By Product, By Route Of Administration (Parenteral, Inhalational), By Application (Asthma, COPD, Diabetes Management, Others), By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 150 Pages
  • November 2022
  • Region: Global
  • Grand View Research
  • ID: 4751775
The global connected drug delivery devices market size is expected to reach USD 25.63 billion by 2030. The market is expected to expand at a lucrative CAGR of 23.45% from 2023 to 2030. Key factors driving the market growth include the need to increase patient medication adherence, R&D initiatives, and the acceleration of remote digital monitoring. In September 2022, Ypsomed for instance, partnered with Sidekick Health to expand Ypsomed's device and SmartServices offering by incorporating a self-injection module into Sidekick's known digital therapeutics solution. Through this, patients with chronic diseases are likely to receive a personalized patient experience due to the integration of Ypsomed's devices with Sidekick's digital health behavioral economics and gamification expertise, and pharmaceutical customers will benefit from a comprehensive service, and leading digital therapy management system.

One of the technological advancements is connected drug delivery, which has a sensor that enables communication and data transfer to servers and apps over cellular, Bluetooth, and Near Field Communication (NFC) networks. One of the main benefits of these connected drug delivery systems is that it gives patients reminders and adherence trackers, reducing the effort needed to comply with the prescribed medication schedule. This further reduces the cost of prescription waste, especially that from the increasingly popular biological injectable drugs that insurance would be required to pay for. Additionally, doctors can monitor how well their patients are adhering to their recommended therapies owing to connected drug delivery systems and change the patient's care as appropriate. For instance, connected drug delivery devices can be beneficial to manage self-medication in persons with chronic diseases like diabetes and asthma. In the upcoming years, these factors are anticipated to accelerate market growth.

Worldwide rising rates of chronic illnesses like COPD, diabetes, and asthma are anticipated to propel the business of connected drug delivery devices. For instance, according to research on estimates of diabetes prevalence for 2021 that was published in January 2022 by the National Library of Medicine and National Center for Biotechnology Information, the disease prevalence among people aged 20 to 79 in 2021 was estimated to be 10.5% and could increase to 12.2% by 2045. Diabetes is thought to affect both men and women equally, however, it is most common in people aged 75 to 79. Additionally, as connected drug delivery devices with greater advantages have become more popular, manual drug administration devices have been increasingly replaced. These factors are anticipated to fuel connected drug market growth.

The global COVID-19 pandemic has had a negative impact and raised the need for healthcare services. This has accelerated the trend of redesigning the healthcare system for improved assistance and quick growth of technology. While most global markets went down in 2020, this market showed unprecedented growth despite difficult conditions and a lockdown in most countries. Due to the lockdown restrictions, there was an unexpected rise in demand for drug delivery systems for use in-home care, which resulted in an increase in demand for connected drug delivery devices.

Connected Drug Delivery Devices Market Report Highlights

  • The global market was valued at USD 4.84 billion in 2022 and is expected to grow at a CAGR of 23.45% during the forecast period
  • The standalone components and software segment is expected to grow for the highest revenue share during the forecast period, owing to the increasing demand for connected sensors to transform traditional drug delivery devices into connected drug delivery devices without interfering with their normal functioning and can be reused even if the device is disposable
  • The parenteral segment is expected to drive market growth during the forecast period, owing to the numerous advantages offered by smart & connected parenteral devices over conventional ones
  • Diabetes Management dominated the market with a share of over 36.23% in 2022. This is owing to factors such as the rising prevalence of diabetes, technological advancements, and R&D in insulin delivery devices
  • North America is expected to dominate the market over the forecast period. This is due to the region’s high per capita healthcare spending, rapid adoption of technology presence of key players, and growing adoption of remote monitoring for medication adherence


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Research Methodology & Scope
1.1 Market Segmentation & Scope
1.1.1 Estimates & Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database:
1.3.2 Internal Database
1.3.3 Secondary sources
1.3.4 Primary Research:
1.3.5 Details of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.7 List of Secondary Sources
1.8 Objectives
Chapter 2 Executive Summary
2.1 Market Snapshot
2.2 Segment Snapshot
2.3 Competitive Landscape Snapshot
Chapter 3 Connected Drug Delivery Devices Market: Market Variables Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Analysis
3.1.2 Ancillary Market Analysis
3.2 Penetration And Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market Driver Analysis
3.3.2 Market Restraint Analysis
3.2.3 Market Opportunity Analysis
3.2.4 Market Challenge Analysis
3.4 Industry Analysis
3.4.1 Porter’s 5 Forces Analysis
3.4.1.1 Bargaining Power of Buyers
3.4.1.2 Bargaining Power of Suppliers
3.4.1.3 Threat of New Entrants
3.4.1.4 Threat of Substitutes
3.4.1.5 Industry Rivalry: High
3.4.2 PESTEL ANALYSIS
3.4.2.1 Political & Legal Landscape
3.4.2.2 Economic & Social Landscape
3.4.2.3 Environmental Landscape
3.4.2.4 Technology Landscape
3.5 R&D/ Product Pipeline Analysis
3.6 Pricing Analysis
3.7 Regulatory & Reimbursement Framework
3.8 Connected Drug Delivery Devices Market: Covid-19 Impact Analysis
Chapter 4 Connected Drug Delivery Devices Market: Product Analysis
4.1 Product Market Share Analysis, 2022 & 2030
4.2 Connected Drug Delivery Devices Market: Product movement analysis, 2018 to 2030
4.3 Standalone Components & Software
4.3.1 Standalone Components & Software market estimates and forecasts, 2018 - 2030 (USD Million)
4.3.2 Integrated Devices
4.3.2.1 Integrated Devices market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 5 Connected Drug Delivery Devices Market: Route of Administration Analysis
5.1 Route of Administration Market Share Analysis, 2022 & 2030
5.2 Connected Drug Delivery Devices Market: Route of Administration movement analysis, 2018 to 2030
5.3 Parenteral
5.3.1 Parenteral market estimates and forecasts, 2018 - 2030 (USD Million)
5.3.2 Inhalational
5.3.2.1 Inhalational market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 6 Connected Drug Delivery Devices Market: Application Analysis
6.1 Application Market Share Analysis, 2022 & 2030
6.2 Connected Drug Delivery Devices Market: Application movement analysis, 2018 to 2030
6.3 Asthma
6.3.1 Asthma market estimates and forecasts, 2018 - 2030 (USD Million)
6.3.2 COPD
6.3.2.1 COPD market estimates and forecasts, 2018 - 2030 (USD Million)
6.3.3 Diabetes Management
6.3.3.1 Diabetes Management market estimates and forecasts, 2018 - 2030 (USD Million)
6.3.4 Others
6.3.4.1 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 7 Connected Drug Delivery Devices Market: Regional Market Analysis, By Product, route of administration, application, distribution channel 2018 - 2030 (USD Million)
7.1 Regional Market Share Analysis, 2022 & 2030
7.2 Regional Market Snapshot
7.3 North America
7.3.1 North America Connected Drug Delivery Devices Market estimates and forecasts by countries, 2018 - 2030 (USD Million)
7.3.2 U.S.
7.3.2.1 U.S. Connected Drug Delivery Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
7.3.3 Canada
7.3.3.1 Canada Connected Drug Delivery Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
7.4 Europe
7.4.1 Europe Connected Drug Delivery Devices Market estimates and forecasts by countries, 2018 - 2030 (USD Million)
7.4.2 U.K.
7.4.2.1 U.K. Connected Drug Delivery Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
7.4.3 Germany
7.4.3.1 Germany Connected Drug Delivery Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
7.4.4 France
7.4.4.1 France Connected Drug Delivery Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
7.4.5 Spain
7.4.5.1 Spain Connected Drug Delivery Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
7.4.6 Italy
7.4.6.1 Italy Connected Drug Delivery Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
7.5 Asia Pacific
7.5.1 Asia Pacific Connected Drug Delivery Devices market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.2 Japan
7.5.2.1 Japan Connected Drug Delivery Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.3 China
7.5.3.1 China Connected Drug Delivery Devices market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.4 India
7.5.4.1 India Connected Drug Delivery Devices market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.5 Australia
7.5.5.1 Australia Connected Drug Delivery Devices market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.6 South Korea
7.5.6.1 South Korea Connected Drug Delivery Devices market estimates and forecasts, 2018 - 2030 (USD Million)
7.6 Latin America
7.6.1 Latin America Connected Drug Delivery Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.2 Brazil
7.6.2.1 Brazil Connected Drug Delivery Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.3 Mexico
7.6.3.1 Mexico Connected Drug Delivery Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.4 Argentina
7.6.4.1 Argentina Connected Drug Delivery Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
7.7 MEA
7.7.1 MEA Connected Drug Delivery Devices market estimates and forecasts by countries, 2018 - 2030 (USD Million)
7.7.2 South Africa
7.7.2.1 South Africa Connected Drug Delivery Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
7.7.3 Saudi Arabia
7.7.3.1 Saudi Arabia Connected Drug Delivery Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 8 Connected Drug Delivery Devices Market - Competitive Analysis
8.1 Teva Respiratory, Llc
8.1.1 Company Overview
8.1.2 Financial Performance
8.1.3 Product Benchmarking
8.1.4 Strategic Initiatives
8.2 Novo Nordisk A/S
8.2.1 Company Overview
8.2.2 Financial Performance
8.2.3 Product Benchmarking
8.2.4 Strategic Initiatives
8.3 Phillips-Medisize, Llc
8.3.1 Company Overview
8.3.2 Financial Performance
8.3.3 Product Benchmarking
8.3.4 Strategic Initiatives
8.4 Medtronic
8.4.1 Company Overview
8.4.2 Financial Performance
8.4.3 Product Benchmarking
8.4.4 Strategic Initiatives
8.5 Adherium Limited
8.5.1 Company Overview
8.5.2 Financial Performance
8.5.3 Product Benchmarking
8.5.4 Strategic Initiatives
8.6 Tandem Diabetes Care, Inc.
8.6.1 Company Overview
8.6.2 Financial Performance
8.6.3 Product Benchmarking
8.6.4 Strategic Initiatives
8.7 Biocorp
8.7.1 Company Overview
8.7.2 Financial Performance
8.7.3 Product Benchmarking
8.7.4 Strategic Initiatives
8.8 Propeller Health
8.8.1 Company Overview
8.8.2 Product Benchmarking
8.8.3 Strategic Initiatives
8.9 Ypsomed Ag
8.9.1 Company Overview
8.9.2 Financial Performance
8.9.3 Product Benchmarking
8.9.4 Strategic Initiatives
8.10 Aptar Pharma
8.10.1 Company Overview
8.10.2 Financial Performance
8.10.3 Product Benchmarking
8.10.4 Strategic Initiatives
8.11 Market Participation Categorization
8.12 Company market position analysis
8.13 List of Key Companies
List of Tables
Table 1 List of secondary sources
Table 2 List of key companies
Table 3 North America Connected Drug Delivery Devices market, by country, 2018 - 2030 (USD Million)
Table 4 North America Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
Table 5 North America Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
Table 6 North America Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
Table 7 U.S. Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
Table 8 U.S. Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
Table 9 U.S. Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
Table 10 Canada Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
Table 11 Canada Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
Table 12 Canada Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
Table 13 Europe Connected Drug Delivery Devices market, by country, 2018 - 2030 (USD Million)
Table 14 Europe Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
Table 15 Europe Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
Table 16 Europe Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
Table 17 U.K. Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
Table 18 U.K. America Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
Table 19 U.K. Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
Table 20 Germany Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
Table 21 Germany Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
Table 22 Germany Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
Table 23 France Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
Table 24 France Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
Table 25 France Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
Table 26 Italy Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
Table 27 Italy Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
Table 28 Italy Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
Table 29 Spain Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
Table 30 Spain Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
Table 31 Spain Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
Table 32 Asia Pacific Connected Drug Delivery Devices market, by country, 2018 - 2030 (USD Million)
Table 33 Asia Pacific Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
Table 34 Asia Pacific Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
Table 35 Asia Pacific Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
Table 36 China Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
Table 37 China Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
Table 38 China Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
Table 39 Japan Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
Table 40 Japan Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
Table 41 Japan Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
Table 42 India Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
Table 43 India Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
Table 44 India Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
Table 45 Australia Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
Table 46 Australia Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
Table 47 Australia Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
Table 48 South Korea Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
Table 49 South Korea Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
Table 50 South Korea Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
Table 51 LATAM Connected Drug Delivery Devices market, by country, 2018 - 2030 (USD Million)
Table 52 LATAM Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
Table 53 LATAM Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
Table 54 LATAM Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
Table 55 Brazil Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
Table 56 Brazil Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
Table 57 Brazil Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
Table 58 Mexico Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
Table 59 Mexico Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
Table 60 Mexico Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
Table 61 Argentina Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
Table 62 Argentina Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
Table 63 Argentina Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
Table 64 MEA Connected Drug Delivery Devices market, by country, 2018 - 2030 (USD Million)
Table 65 MEA Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
Table 66 MEA Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
Table 67 MEA Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
Table 68 South Africa Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
Table 69 South Africa Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
Table 70 South Africa Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
Table 71 Saudi Arabia Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
Table 72 Saudi Arabia Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
Table 73 Saudi Arabia Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
Table 74 Global Connected Drug Delivery Devices market, by region, 2018 - 2030 (USD Million)
Table 75 Global Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
Table 76 Global Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
Table 77 Global Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Commodity flow analysis
Fig. 10 Penetration & growth prospect mapping
Fig. 11 Market trends & outlook
Fig. 12 Market driver relevance analysis (Current & future impact)
Fig. 13 Market restraint relevance analysis (Current & future impact)
Fig. 14 Connected Drug Delivery Devices Market product outlook: Key takeaways
Fig. 15 Connected Drug Delivery Devices Market: Product movement analysis
Fig. 16 Global Standalone components & software market 2018 - 2030 (USD Million)
Fig. 17 Global Integrated devices market 2018 - 2030 (USD Million)
Fig. 18 Connected Drug Delivery Devices Market Route of Administration outlook: Key takeaways
Fig. 19 Connected Drug Delivery Devices Market: Route of Administration movement analysis
Fig. 20 Global Parenteral market 2018 - 2030 (USD Million)
Fig. 21 Global Inhalational market 2018 - 2030 (USD Million)
Fig. 22 Connected Drug Delivery Devices Market Application outlook: Key takeaways
Fig. 23 Connected Drug Delivery Devices Market: Application movement analysis
Fig. 24 Global Asthma market 2018 - 2030 (USD Million)
Fig. 25 Global COPD market 2018 - 2030 (USD Million)
Fig. 26 Global Diabetes Management market 2018 - 2030 (USD Million)
Fig. 27 Global Others market 2018 - 2030 (USD Million)
Fig. 28 Regional outlook, 2022 & 2030
Fig. 29 Regional marketplace: Key takeaways
Fig. 30 North America Connected Drug Delivery Devices Market by countries, 2018 - 2030 (USD Million)
Fig. 31 U.S. Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
Fig. 32 Canada Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
Fig. 33 Europe Connected Drug Delivery Devices market by countries, 2018 - 2030 (USD Million)
Fig. 34 U.K. Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
Fig. 35 Germany Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
Fig. 36 France Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
Fig. 37 Spain Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
Fig. 38 Italy Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
Fig. 39 Asia Pacific Connected Drug Delivery Devices market by countries, 2018 - 2030 (USD Million)
Fig. 40 China Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
Fig. 41 India Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
Fig. 42 Australia Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
Fig. 43 South Korea Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
Fig. 44 Japan Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
Fig. 45 Latin America Connected Drug Delivery Devices market by countries, 2018 - 2030 (USD Million)
Fig. 46 Brazil Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
Fig. 47 Mexico Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
Fig. 48 Argentina Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
Fig. 49 MEA Connected Drug Delivery Devices market by countries, 2018 - 2030 (USD Million)
Fig. 50 South Africa Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
Fig. 51 Saudi Arabia Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
Fig. 52 Market Participant categorization
Fig. 53 Company market position analysis

Companies Mentioned

  • Teva Respiratory, LLC
  • Novo Nordisk A/S
  • Phillips-Medisize, LLC
  • Medtronic
  • Adherium Limited
  • Tandem Diabetes Care, Inc.
  • Biocorp
  • Propeller Health
  • Ypsomed AG
  • Aptar Pharma

Methodology

Loading
LOADING...